| Hsu CS, Kao JH
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C. [Comment, Letter]
N Engl J Med 2009 Oct 29; 361(18):1808-9; author reply 1809.
Full Citation | Find Related Articles |
| Breilh D, Djabarouti S, Trimoulet P, et al.
Ribavirin Plasma Concentration Predicts Sustained Virological Response to Peginterferon Alfa 2a Plus Ribavirin in Previously Treated HCV-HIV-Coinfected Patients. [JOURNAL ARTICLE]
J Acquir Immune Defic Syndr 2009 Nov; 52(3):428-430.
Full Citation | Find Related Articles |
| Chan-Tack KM, Murray JS, Birnkrant DB
Use of ribavirin to treat influenza. [Letter]
N Engl J Med 2009 Oct 22; 361(17):1713-4.
Full Citation | Find Related Articles |
| Zhang Y, Zhu Z, Zhu SL, et al.
[In vitro study on the effect of ribavirin reducing the EV71 replication] [English Abstract, Journal Article]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2009 Feb; 23(1):44-6.
Abstract | Full Citation | Find Related Articles |
| Ku JY, Sharma A
Pegylated interferon and ribavirin therapy for hepatitis C causing cataract. [Letter]
Clin Experiment Ophthalmol 2009 Sep; 37(7):743-5.
Full Citation | Publisher Full Text | Find Related Articles |
| Kumar A, Grayson MH
The role of viruses in the development and exacerbation of atopic disease. [Journal Article, Research Support, Non-U.S. Gov't]
Ann Allergy Asthma Immunol 2009 Sep; 103(3):181-6; quiz 186-7, 219.
Abstract | Full Citation |
| Moreno López R, Sicilia Aladrén B, Gomollón García F
Use of agents stimulating erythropoiesis in digestive diseases. [Journal Article]
World J Gastroenterol 2009 Oct 7; 15(37):4675-85.
Abstract | Full Citation |
| Corey KE, Kane E, Munroe C, et al.
Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long-term follow-up. [JOURNAL ARTICLE]
Hepatology 2009 Aug 10; 50(4):1030-1037.
Abstract | Full Citation |
| Nelson DR
Hepatitis C drug development at a crossroads. [JOURNAL ARTICLE]
Hepatology 2009 Aug 5; 50(4):997-999.
Full Citation | Find Related Articles |
| Mira JA, Gutiérrez-Valencia A, Gil ID, et al.
Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Sep 22.
Abstract | Full Citation | Find Related Articles |
  |
